Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

Latest News

The Latest: S. Korean diva sings at North Korean volcano

Sep 21, 2018

SEOUL, South Korea — The Latest on the summit between North Korean leader Kim Jong Un and South Korean President Moon Jae-in (all times local): 8 p.m. A South Korean pop singer has belted out a beloved Korean folk song in front of North Korean leader Kim Jong Un and South Korean President Moon Jae-in at a crater lake atop a volcano North Korea considers as sacred. Singer Ali was among the South Koreans who joined the leaders on a trip to Mount Paektu on the North Korean-Chinese border hours before they returned home on Thursday after three days of...

The Latest: Trump welcomes 'tremendous progress' with NKorea

Sep 21, 2018

PYONGYANG, North Korea — The Latest on the summit between North Korean leader Kim Jong Un and South Korean President Moon Jae-in (all times local): 11 p.m. U.S. President Donald Trump says "we're making tremendous progress" with North Korea, after an inter-Korean summit offered some apparent concessions from the North on its weapons program. Trump told reporters Wednesday that "we had very good news" out of the summit, where leader Kim Jong Un promised to dismantle a rocket launch site and also agreed to dismantle its main nuclear site if the U.S. takes unspecified corresponding measures. Trump didn't indicate in...

China reaches out to US over demand for media registration

Sep 21, 2018

BEIJING — China has reached out to the U.S. over reports that the Department of Justice has ordered two top Chinese state-run news outlets to register as foreign agents, a spokesman said Wednesday, adding that Beijing opposed "politicizing" the role of the media. Foreign Ministry spokesman Geng Shuang said that Beijing had "contacted and communicated" with the U.S. side over the issue, but gave no details. "Media serve as an important bridge and link to help the people from different countries to better understand and communicate with each other," Geng told reporters at a daily briefing. "We should provide convenience...

Summit may be the grand theater Kim needs to show his people

Sep 21, 2018

SEOUL, South Korea — If North Korean leader Kim Jong Un was searching for the perfect propaganda set piece, something designed to show his people that he's a strong leader pushing inexorably for the long-delayed, long-promised prosperity they deserve, then visiting South Korean President Moon Jae-in might be providing him with a unique opportunity. Moon believes that his deep engagement with North Korea is crucial after last year's fears of war, when Washington reacted with fury to a torrent of ever-more-powerful North Korean weapons tests. He argues better ties with North Korea will help South Koreans, and the region, by...

Moonstruck Japan tycoon to blast off on 1st SpaceX trip

Sep 21, 2018

TOKYO — The Japanese billionaire who Tesla chief Elon Musk says plans to blast off on the first-ever private commercial space trip aboard the SpaceX Big Falcon Rocket often makes headlines in Japan. The SpaceX mission, set for takeoff in 2023, is just the latest exploit in tycoon Yusaku Maezawa's colorful and ambitious career: ___ FASHION BRAND Maezawa, 42, is the chief executive of Start Today Co., which he founded in 1998 as a CD sales business when he was still in his 20s. The company pioneered e-commerce in Japan and now runs the popular fashion mall Zozotown, selling various,...

Sign up now!